Affordable Access

CaMKII Inhibition in Heart Failure, Beneficial, Harmful, or Both

  • Biology
  • Physiology
  • Calmodulin-Dependent Protein Kinase Ii
  • Calcium Channel
  • Myocytes
  • Excitation-Contraction Coupling
  • Calcium Handling
  • Diastolic Function
  • Biology
  • Medicine


Calmodulin-dependent protein kinase II (CaMKII) has been proposed to be a therapeutic target for heart failure (HF). However, the cardiac effect of chronic CaMKII inhibition in HF has not been well understood. We have tested alterations of Ca2+ handling, excitation-contraction coupling, and in vivo β-adrenergic regulation in pressure-overload HF mice with CaMKIIδ knockout (KO). HF was produced in wild-type (WT) and KO mice 1 wk after severe thoracic aortic banding (sTAB) with a continuous left ventricle (LV) dilation and reduction of ejection fraction for up to 3 wk postbanding. Cardiac hypertrophy was similar between WT HF and KO HF mice. However, KO HF mice manifested exacerbation of diastolic function and reduction in cardiac reserve to β-adrenergic stimulation. Compared with WT HF, L-type calcium channel current (ICa) density in KO HF LV was decreased without changes in ICa activation and inactivation kinetics, whereas ICa recovery from inactivation was accelerated and Ca2+-dependent ICa facilitation, a positive staircase blunted in WT HF, was recovered. However, ICa response to isoproterenol was reduced. KO HF myocytes manifested dramatic decrease in sarcoplasmic reticulum (SR) Ca2+ leak and slowed cytostolic Ca2+ concentration decline. Sarcomere shortening was increased, but relaxation was slowed. In addition, an increase in myofilament sensitivity to Ca2+ and the slow skeletal muscle troponin I-to-cardiac troponin I ratio and interstitial fibrosis and a decrease in Na/Ca exchange function and myocyte apoptosis were observed in KO HF LV. CaMKIIδ KO cannot suppress severe pressure-overload-induced HF. Although cellular contractility is improved, it reduces in vivo cardiac reserve to β-adrenergic regulation and deteriorates diastolic function. Our findings challenge the strategy of CaMKII inhibition in HF.

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times

More articles like this

CaMKII inhibition in heart failure, beneficial, ha...

on American journal of physiology... Apr 01, 2012

CaMKII inhibition in heart failure makes jump to h...

on Circulation Research Oct 29, 2010

The promise of CaMKII inhibition for heart disease...

on Expert Opinion on Therapeutic... August 2013
More articles like this..